During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

For many reasons, including sensitivity and stigma surrounding the locations of these cancers, gynaecological cancers are ...

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck ...

Adapted Argentine tango dance therapy is helping some breast cancer survivors regain natural balance and sensation after experiencing neuropathy, a common side effect of chemotherapy treatment.

First Lady Oluremi Tinubu’s Renewed Hope Initiative (RHI) has announced a N1 billion donation to the fight against cervical cancer by the National Cancer Fund. The donation, which coincided with ...

Nigeria’s First Lady, Oluremi Tinubu, has promised to donate N1 billion to support cervical cancer treatment among women. She said this is in furtherance of efforts to eradicate the disease from ...

She was speaking while receiving a delegation of the National Taskforce on Cervical Cancer Elimination led by the Minister of State for Health and Social Welfare, Dr Iziaq Adekunle Salako.

The donation, made on behalf of her Renewed Hope Initiative (RHI), was announced during a visit by the National Taskforce on Cervical Cancer Elimination to the First Lady at the State House.

ABUJA — THE First Lady, Senator Oluremi Tinubu has donated One billion naira to the National Cancer Fund to aid in the fight against the menace of Cervical Cancer scourge in Nigeria This is as ...

The vast majority of Medicare's top-selling brand-name oncology drugs in 2022 provided high added therapeutic benefit. Ten drugs were classified as low or no added therapeutic benefit compared ...

CX-4945 significantly prolonged survival in advanced cancer patients, marking a major milestone for ... as a monotherapy or in combination with the second-line immunotherapy Libtayo. The company aims ...